B. Uz Et Al. , "Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation," CASE REPORTS IN HEMATOLOGY , 2011
Uz, B. Et Al. 2011. Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation. CASE REPORTS IN HEMATOLOGY .
Uz, B., Bektas, O., Eliacik, E., GÖKER, H., ERBİLGİN, Y., SAYİTOĞLU, M., ... SAYINALP, N.(2011). Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation. CASE REPORTS IN HEMATOLOGY .
Uz, B. Et Al. "Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation," CASE REPORTS IN HEMATOLOGY , 2011
Uz, B. Et Al. "Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation." CASE REPORTS IN HEMATOLOGY , 2011
Uz, B. Et Al. (2011) . "Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation." CASE REPORTS IN HEMATOLOGY .
@article{article, author={B. Uz Et Al. }, title={Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation}, journal={CASE REPORTS IN HEMATOLOGY}, year=2011}